BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: Understanding the evolving relationship. World J Gastroenterol 2010; 16(39): 4892-4904 [PMID: 20954275 DOI: 10.3748/wjg.v16.i39.4892]
URL: https://www.wjgnet.com/1007-9327/full/v16/i39/4892.htm
(0) (0) (15298) (81)
Number Citing Articles
1
F De Luca, Y Shoenfeld. The microbiome in autoimmune diseases. Clinical and Experimental Immunology 2018; 195(1) doi: 10.1111/cei.13158
2
N. M. Alkhalidi, M. A. Abdullah, A. A. Mjali. Clostridium Difficile Infection and Infl ammatory Bowel Diseases: Frequency and Possible Risk Factors. Experimental and Clinical Gastroenterology 2026; (12) doi: 10.31146/1682-8658-ecg-244-12-28-39
3
Petros Zezos, Fred Saibil. Inflammatory pouch disease: The spectrum of pouchitis. World Journal of Gastroenterology 2015; 21(29): 8739-8752 doi: 10.3748/wjg.v21.i29.8739
4
Geeta Kulkarni, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020;  doi: 10.1016/B978-0-12-814811-2.00023-2
5
Prashanna Balaji Venkatasubramanian, Els Oosterink, Monic M. M. Tomassen, Maria Suarez-Diez, Jurriaan J. Mes, Edoardo Saccenti, Nicole J. W. de Wit. Transcriptome-based identification of the beneficial role of blackcurrant, strawberry and yellow onion to attenuate the cytopathic effects of Clostridium difficile toxins. Journal of Berry Research 2021; 11(2) doi: 10.3233/JBR-200646
6
Hyun Sik Kim, Yeon-Ah Lee. Microbiome in Autoimmune Diseases: Present and Future. The Korean Journal of Medicine 2026; 101(1) doi: 10.3904/kjm.2026.101.1.4
7
Sai-Long Zhang, Shu-Na Wang, Chao-Yu Miao. Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01674
8
Cristiana De Musis, Lucia Granata, Marcello Dallio, Agnese Miranda, Antonietta G. Gravina, Marco Romano. Inflammatory Bowel Diseases: The Role of Gut Microbiota. Current Pharmaceutical Design 2020; 26(25) doi: 10.2174/1381612826666200420144128
9
Christoph Becker, Markus F. Neurath, Stefan Wirtz. The Intestinal Microbiota in Inflammatory Bowel Disease. ILAR Journal 2015; 56(2) doi: 10.1093/ilar/ilv030
10
Revital Kariv, Udayakumar Navaneethan, Preethi G.K. Venkatesh, Rocio Lopez, Bo Shen. Impact of Clostridium difficile infection in patients with ulcerative colitis. Journal of Crohn's and Colitis 2011; 5(1) doi: 10.1016/j.crohns.2010.09.007
11
Udayakumar Navaneethan, Saurabh Mukewar, Preethi GK Venkatesh, Rocio Lopez, Bo Shen. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. Journal of Crohn's and Colitis 2012; 6(3) doi: 10.1016/j.crohns.2011.09.005
12
Current World Literature. Current Opinion in Neurology 2011; 24(3) doi: 10.1097/WCO.0b013e328347b40e
13
Jiang-Chen Peng, Jun Shen, Qi Zhu, Zhi-Hua Ran. The Impact of Clostridum Difficile on Surgical Rate Among Ulcerative Colitis Patients: A Systemic Review and Meta-analysis. Saudi Journal of Gastroenterology 2015; 21(4) doi: 10.4103/1319-3767.161644
14
Henning Sommermeyer, Jacek Piątek. Clostridioides difficile. 2021;  doi: 10.1007/978-3-030-81100-6_5
15
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficile. Journal of Parenteral and Enteral Nutrition 2012; 36(6) doi: 10.1177/0148607112446703
16
Meeta Desai, Kristin Knight, James M. Gray, Vu Nguyen, James Boone, Dario Sorrentino. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2020; 32(9) doi: 10.1097/MEG.0000000000001762
17
Mohammad Abdehagh, Masoumeh Azimirad, Hamidreza Houri, Banafsheh Nadalian, Fahimeh Azimirad, Meysam Olfatifar, Ome Kolsoum Nasir Shoeibi, Abbas Yadegar, Shabnam Shahrokh, Mehran Mahdavi Roshan, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06804-2
18
Henry A. Horton, Gil Y. Melmed. Clostridium difficile in Inflammatory Bowel Disease. Seminars in Colon and Rectal Surgery 2012; 23(2) doi: 10.1053/j.scrs.2012.02.004
19
Angela Vassallo, Mai-Chi N Tran, Ellie JC Goldstein. Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Review of Anti-infective Therapy 2014; 12(9) doi: 10.1586/14787210.2014.942284
20
Gabriela Muniz Carvalho, Carolina Pantuzza Ramos, Francisco Carlos Faria Lobato, Roberto Maurício Carvalho Guedes, Paula Roberta Giaretta, Rodrigo Otávio Silveira Silva. Laboratory diagnosis of Clostridioides (Clostridium) difficile infection in domestic animals: A short review. Anaerobe 2022; 75 doi: 10.1016/j.anaerobe.2022.102574
21
Geeta Kulkarni, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2026;  doi: 10.1016/B978-0-443-29172-2.00002-8
22
Role of Medicinal Plants in Autoimmune Diseases. 2025;  doi: 10.1016/B978-0-443-18776-6.00003-7
23
Asghar Ali, Khalid I. AlHussaini. Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1740387
24
Esi S.N. Lamousé‐Smith, Sarah Weber, Richard F. Rossi, Liliane J. Neinstedt, Nima Mosammaparast, Thomas J. Sandora, Alexander J. McAdam, Athos Bousvaros. Polymerase Chain Reaction Test for Clostridium difficile Toxin B Gene Reveals Similar Prevalence Rates in Children With and Without Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(3) doi: 10.1097/MPG.0b013e3182999990
25
Sandra Dedrick, Bharathi Sundaresh, Qian Huang, Claudia Brady, Tessa Yoo, Catherine Cronin, Caitlin Rudnicki, Michael Flood, Babak Momeni, Johnny Ludvigsson, Emrah Altindis. The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00078
26
Hiroyuki Kunishima, Hiroki Ohge, Hiromichi Suzuki, Atsushi Nakamura, Kazuaki Matsumoto, Hiroshige Mikamo, Nobuaki Mori, Yoshitomo Morinaga, Katsunori Yanagihara, Yuka Yamagishi, Sadako Yoshizawa. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. Journal of Infection and Chemotherapy 2022; 28(8) doi: 10.1016/j.jiac.2021.12.011
27
Kelly C. Sandberg, Matthew M. Davis, Achamyeleh Gebremariam, Jeremy Adler. Increasing Hospitalizations in Inflammatory Bowel Disease Among Children in the United States, 1988–2011. Inflammatory Bowel Diseases 2014; 20(10) doi: 10.1097/MIB.0000000000000195
28
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update. Surgery 2017; 162(2) doi: 10.1016/j.surg.2017.01.018
29
Parisa Shoaei, Hasan Shojaei, Mohammad Jalali, Farzin Khorvash, Sayed Mohsen Hosseini, Behrooz Ataei, Bahareh Vakili, Fatemeh Ebrahimi, Hossein Tavakoli, Zahra Esfandiari, J. Scott Weese. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3965-8
30
Idan Goren, Ortal Fallek Boldes, Tomer Boldes, Oleg Knyazev, Anna Kagramanova, Jimmy K Limdi, Eleanor Liu, Karishma Sethi-Arora, Tom Holvoet, Piotr Eder, Cristina Bezzio, Simone Saibeni, Marta Vernero, Eleonora Alimenti, María Chaparro, Javier P Gisbert, Eleni Orfanoudaki, Ioannis E Koutroubakis, Daniela Pugliese, Giuseppe Cuccia, Cristina Calviño Suarez, Davide Giuseppe Ribaldone, Ido Veisman, Kassem Sharif, Stefano Festa, Annalisa Aratari, Claudio Papi, Iordanis Mylonas, Gerassimos J Mantzaris, Marie Truyens, Triana Lobaton Ortega, Stéphane Nancey, Fabiana Castiglione, Olga Maria Nardone, Giulio Calabrese, Konstantinos Karmiris, Magdalini Velegraki, Angeliki Theodoropoulou, Ariella Bar-Gil Shitrit, Milan Lukas, Gabriela Vojtechová, Pierre Ellul, Luke Bugeja, Edoardo V Savarino, Tali Sharar Fischler, Iris Dotan, Henit Yanai. Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection. Journal of Crohn's and Colitis 2025; 19(5) doi: 10.1093/ecco-jcc/jjae161
31
Massimo Martinelli, Caterina Strisciuglio, Gabor Veres, Anders Paerregaard, Ana M. Pavic, Marina Aloi, Javier Martín-de-Carpi, Arie Levine, Dan Turner, Mariassunta Del Pezzo, Annamaria Staiano, Erasmo Miele. Clostridium difficile and Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(12) doi: 10.1097/MIB.0000000000000219
32
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk. Introduction to Gastrointestinal Diseases Vol. 1. 2017;  doi: 10.1007/978-3-319-49016-8_6
33
Francesca McDonagh, Martin Cormican, Dearbháile Morris, Liam Burke, Nitin Kumar Singh, Kasthuri Venkateswaran, Georgios Miliotis. Medical Astro-Microbiology: Current Role and Future Challenges. Journal of the Indian Institute of Science 2023; 103(3) doi: 10.1007/s41745-023-00360-1
34
Osama Nadeem, Muhammad Soban Imran, Nasir Siddique. Recurrent Clostridium difficile Infections in a Patient With Ulcerative Colitis: A Case Report. Cureus 2025;  doi: 10.7759/cureus.95130
35
Leslie Sangurima, Maujid Masood Malik, Nency Ganatra, Rosemary Siby, Sanjay Kumar, Sara Khan, Doju Cheriachan, Lubna Mohammed. Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management. Cureus 2023;  doi: 10.7759/cureus.43134
36
Anže Smole, Duško Lainšček, Urban Bezeljak, Simon Horvat, Roman Jerala. A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. Molecular Therapy 2017; 25(1) doi: 10.1016/j.ymthe.2016.10.005
37
Yongchun Li, Lili Sheng, Prasant Kumar Jena, Miranda Claire Gilbert, Yu-Jui Yvonne Wan, Hua Mao. Retinoic Acid Signaling Is Compromised in DSS-Induced Dysbiosis. Nutrients 2022; 14(14) doi: 10.3390/nu14142788
38
Kristie Chow, Yingfu Li. Functional Nucleic Acids as Bacterial Biosensors: A Focus on Clostridioides difficile Infection. Analysis & Sensing 2025; 5(2) doi: 10.1002/anse.202400056
39
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis. World Journal of Pediatrics 2022; 18(1) doi: 10.1007/s12519-021-00486-1
40
Torsten Kucharzik, Christian Maaser. Infections and Chronic Inflammatory Bowel Disease. Visceral Medicine 2014; 30(5) doi: 10.1159/000366463
41
Rodrigo Otávio Silveira Silva, Carlos Augusto de Oliveira Júnior, Dominique S. Blanc, Silvia Trindade Pereira, Mário Cesar Rennó de Araujo, Artur Vasconcelos, Francisco Carlos Faria Lobato. Clostridioides difficile infection in dogs with chronic-recurring diarrhea responsive to dietary changes. Anaerobe 2018; 51 doi: 10.1016/j.anaerobe.2018.03.011
42
Chao Sun, Peng Du, Xian-rui Wu, Elaine Queener, Bo Shen. Preoperative Clostridium difficile Infection Is Not Associated with an Increased Risk for the Infection in Ileal Pouch Patients. Digestive Diseases and Sciences 2014; 59(6) doi: 10.1007/s10620-014-3047-0
43
Jie Lv, Ruichen Liu, Zhan Sun, Jing Zhang, Yingna Zhang, Xue Zhao, Jing Liu, Xinyue Zhou, Mengdi Zhang, Qian Liu, Feng Gao. Gut Microbiota as Neuroimmune Modulators in Myasthenia Gravis: Mechanistic Insights from the Gut-Brain Axis to Therapeutic Innovations. The American Journal of Chinese Medicine 2026; 54(01) doi: 10.1142/S0192415X26500023
44
Siân Bill, Angharad Dwynwen Barklam. Nursing Care of Children and Young People with Long‐Term Conditions. 2020;  doi: 10.1002/9781119653134.ch1
45
Yuying Liu, Jasmin Freeborn, Shabba A. Armbrister, Dat Q. Tran, Jon Marc Rhoads. Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis. Pediatric Research 2022; 91(1) doi: 10.1038/s41390-021-01445-2
46
Fabian Sanchis-Gomar, Giuseppe Lippi. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities. World Journal of Gastroenterology 2017; 23(47): 8283-8290 doi: 10.3748/wjg.v23.i47.8283
47
Angela Y. Lam, Liat S. Gutin, Yume Nguyen, Fernando S. Velayos. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2020; 65(11) doi: 10.1007/s10620-020-06521-x
48
Behnaz Deihim, Parisa Masoudipour. Antibiotic resistance of enteropathogenic bacteria in a teaching hospital in North Khuzestan during a three-year period. Journal of Family Medicine and Primary Care 2024; 13(5) doi: 10.4103/jfmpc.jfmpc_1594_23
49
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials 2021; 11(8) doi: 10.3390/nano11082035
50
Nitsan Maharshak, Idan Barzilay, Hasya Zinger, Keren Hod, Iris Dotan. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease. Medicine 2018; 97(5) doi: 10.1097/MD.0000000000009772
51
Khyati Girdhar, Qian Huang, I-Ting Chow, Tommi Vatanen, Claudia Brady, Amol Raisingani, Patrick Autissier, Mark A. Atkinson, William W. Kwok, C. Ronald Kahn, Emrah Altindis. A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proceedings of the National Academy of Sciences 2022; 119(31) doi: 10.1073/pnas.2120028119
52
Mustafa Gandhi, Harleen Kaur Chela, Maxwell A. Barffour, Emily Bosak, Emily Reznicek, Kevin Luton, Matthew Bechtold, Yezaz A. Ghouri. Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease. Biologics 2025; 5(4) doi: 10.3390/biologics5040038
53
Yang Song, Shashank Garg, Mohit Girotra, Cynthia Maddox, Erik C. von Rosenvinge, Anand Dutta, Sudhir Dutta, W. Florian Fricke, Gabriele Berg. Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. PLoS ONE 2013; 8(11) doi: 10.1371/journal.pone.0081330
54
Lauren E. Fuess, Stijn den Haan, Fei Ling, Jesse N. Weber, Natalie C. Steinel, Daniel I. Bolnick, John F. Rawls, Margaret J. McFall-Ngai. Immune Gene Expression Covaries with Gut Microbiome Composition in Stickleback. mBio 2021; 12(3) doi: 10.1128/mBio.00145-21
55
Nadera A. Altork, Thomas Chameli, Advait M. Suvarnakar, Lindsay R. Ayers, Amer Arman, Mina Al-Hamadani, Spyridon Peppas, Akram I. Ahmad, Jiling Chou, Mark C. Mattar. Does Clostridioides difficile infection play a role in premalignant colonic lesions? A retrospective cohort study. European Journal of Gastroenterology & Hepatology 2025; 37(10) doi: 10.1097/MEG.0000000000003007
56
Mi Na Kim, Seong-Joon Koh, Jung Mogg Kim, Jong Pil Im, Hyun Chae Jung, Joo Sung Kim. <italic>Clostridium difficile</italic> infection aggravates colitis in interleukin 10-deficient mice. World Journal of Gastroenterology 2014; 20(45): 17084-17091 doi: 10.3748/wjg.v20.i45.17084
57
Rahul S. Dalal, Jessica R. Allegretti. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Current Opinion in Gastroenterology 2021; 37(4) doi: 10.1097/MOG.0000000000000739
58
Rosario Lucas López, María José Grande Burgos, Antonio Gálvez, Rubén Pérez Pulido. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS 2017; 125(1) doi: 10.1111/apm.12609
59
Manuela G. Neuman, Radu M. Nanau. Inflammatory bowel disease: role of diet, microbiota, life style. Translational Research 2012; 160(1) doi: 10.1016/j.trsl.2011.09.001
60
J. Michael Klatte, Rangaraj Selvarangan, Mary Anne Jackson, Angela L. Myers. Reducing Overutilization of Testing for Clostridium difficile Infection in a Pediatric Hospital System: A Quality Improvement Initiative. Hospital Pediatrics 2016; 6(1) doi: 10.1542/hpeds.2015-0116
61
Parul Berry, Sahil Khanna. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies. BioDrugs 2023; 37(6) doi: 10.1007/s40259-023-00617-2
62
Allan Mabardy, Justin Mccarty, Alan Hackford, Haisar Dao. IBD: A Growing and Vulnerable Cohort of Hospitalized Patients with Clostridium difficile Infection. The American Surgeon™ 2017; 83(6) doi: 10.1177/000313481708300625
63
Ying M. Tang, Christian D. Stone. Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment. Clinical Journal of Gastroenterology 2017; 10(2) doi: 10.1007/s12328-017-0719-2
64
Maria Rogalidou. Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges. Frontiers in Pediatrics 2026; 13 doi: 10.3389/fped.2025.1753289
65
Jae Hee Cheon, Won Ho Kim. Atlas of Inflammatory Bowel Diseases. 2015;  doi: 10.1007/978-3-642-39423-2_1
66
Israr Khan, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che, Chunjiang Zhang. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019; 8(3) doi: 10.3390/pathogens8030126
67
Anita Krishnarao, Lauren de Leon, Renee Bright, Heather Moniz, Meaghan Law, Neal Leleiko, Bruce E. Sands, Marjorie Merrick, Jason Shapiro, Sylvan Wallenstein, Julie Giacalone, Samir A. Shah. Testing for Clostridium difficile in Patients Newly Diagnosed with Inflammatory Bowel Disease in a Community Setting. Inflammatory Bowel Diseases 2015; 21(3) doi: 10.1097/MIB.0000000000000309
68
Leon M. T. Dicks, Lasse S. Mikkelsen, Erik Brandsborg, Harold Marcotte. Clostridium difficile, the Difficult “Kloster” Fuelled by Antibiotics. Current Microbiology 2019; 76(6) doi: 10.1007/s00284-018-1543-8
69
David Elisha Henry, V. Venkateswara Rao. Probiotic Research in Therapeutics. 2021;  doi: 10.1007/978-981-33-6236-9_6
70
Dipesh Solanky, Darrell S Pardi, Edward V Loftus, Sahil Khanna. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflammatory Bowel Diseases 2019; 25(3) doi: 10.1093/ibd/izy291
71
Anaberta Bermúdez Naveira, María Mercedes Liñares Paz, Carmen Villalba Martín, Antonio Luna. Learning Abdominal Imaging. Learning Imaging 2012;  doi: 10.1007/978-3-540-88003-5_9
72
Femke-Anouska Heinsen, Henrik Knecht, Sven C Neulinger, Ruth A Schmitz, Carolin Knecht, Tanja Kühbacher, Philip C Rosenstiel, Stefan Schreiber, Anette K Friedrichs, Stephan J Ott. Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes 2015; 6(4) doi: 10.1080/19490976.2015.1062959
73
Daryl D. DePestel, David M. Aronoff. Epidemiology of Clostridium difficile Infection. Journal of Pharmacy Practice 2013; 26(5) doi: 10.1177/0897190013499521
74
Israr Khan, Yanrui Bai, Naeem Ullah, Guanlan Liu, Muhammad Shahid Riaz Rajoka, Chunjiang Zhang, Jiong Yu. Differential Susceptibility of the Gut Microbiota to DSS Treatment Interferes in the Conserved Microbiome Association in Mouse Models of Colitis and Is Related to the Initial Gut Microbiota Difference. Advanced Gut & Microbiome Research 2022; 2022 doi: 10.1155/2022/7813278
75
Walter Reinisch, Andrew R. Reinink, Peter D.R. Higgins. Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2015; 13(4) doi: 10.1016/j.cgh.2014.03.037
76
Gabie K.B. Ong, Tobi J. Reidy, Matthew D. Huk, Frederick R. Lane. Clostridium difficile colitis: A clinical review. The American Journal of Surgery 2017; 213(3) doi: 10.1016/j.amjsurg.2016.10.035
77
Meng-Xia Wang, Li Lin, Yong-Da Chen, Yu-Ping Zhong, Yi-Xuan Lin, Pei Li, Xing Tian, Bo Han, Zhi-Yong Xie, Qiong-Feng Liao. Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. Pharmacological Research 2020; 159 doi: 10.1016/j.phrs.2020.104978
78
D. S. Purgina, L. V. Lyalina, V. V. Rassokhin. Clostridium diffi cile infection and its eff ect on the course of infl ammatory bowel diseases. Clinical Medicine (Russian Journal) 2022; 100(7-8) doi: 10.30629/0023-2149-2022-100-7-8-346-356
79
Takashi Saito, Yoko Sato, Seiichiro Yamamoto. Antimicrobial Combinations as Novel Indicators for Clostridioides difficile infection development: Population-Based, Nested Case-Controlled Study in Japan—The Shizuoka Kokuho Database Study. Journal of Infection and Chemotherapy 2025; 31(2) doi: 10.1016/j.jiac.2024.11.002
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.